Early onset and persistent progression of coronary artery disease of unknown etiology in a 30-year-old man by Piątek, Jacek et al.
POLISH ARCHIVES OF INTERNAL MEDICINE 2017; 127 (10)698
a non ‑ST ‑segment elevation myocardial infarc‑
tion in March 2011. He also suffered from par‑
oxysmal atrial fibrillation and preexcitation syn‑
drome. A family history of cardiovascular diseas‑
es and diabetes was negative. The predicted 4 ‑year 
mortality assessed with the SYNTAX II score was 
6.4% for percutaneous coronary intervention 
and 0.7% for coronary artery bypass grafting 
(coronary angiography is presented in FIGURE 1A 
and 1B). The patient thus underwent emergent 
coronary artery bypass surgery with 3 arterial 
grafts, using the left and right internal mamma‑
ry arteries (LIMA and RIMA) and the radial ar‑
tery (RA): RIMA to the LAD, LIMA to the first 
The prevalence of coronary artery disease (CAD) 
in young patients is difficult to establish as most 
cases remain subclinical.1 The etiology and patho‑
genesis of atherosclerosis is complex. Its progres‑
sion is particularly rapid when environmental fac‑
tors coexist with genetic ones. An early and accu‑
rate identification of individuals at increased risk 
of CAD is critical for effective prevention and in‑
tervention, such as statin treatment.2 Neverthe‑
less, young smokers with hypertension and high 
fasting glucose levels have a higher probability of 
unsatisfactory results of lipid ‑lowering therapy.3
A 29 ‑year ‑old man with risk factors of hy‑
pertension and smoking was diagnosed with 
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FIGURE 1 Preoperative and follow ‑up imaging of the coronary arteries (arrows); A – coronary angiography showing 
left artery dominance with significant ostial stenosis of the left anterior descending (LAD) artery (99%), first marginal 
branch (99%), and circumflex artery (80%); B – coronary angiography showing the right coronary artery with no 
atherosclerotic lesions
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disorders were excluded with hyperlipidemia gene 
testing and statin myopathy variants.
Familial hypercholesterolemia, which results 
from a heterozygous pathogenic variant in one of 
the several genes (APOB, LDLR, and PCSK9), is 
a relatively common disorder with a prevalence of 
1:200 to 1:250 in the general population.4 The pan‑
el targeted protein ‑coding exons and exon–intron 
gene boundaries, including mutations located 
outside these coding regions. All analyzed nucle‑
otides were covered with a median depth of 585x. 
The test was suitable for identifying single nucle‑
otide variants and insertions and deletions; how‑
ever, it did not identify large copy ‑number vari‑
ations due to limitations of the next ‑generation 
sequencing technique. Large deletions or dupli‑
cations represent up to 10% of the pathogen‑
ic variants in the LDLR gene,5 which could ex‑
plain the negative result. Therefore, we suspect 
that the patient’s disease was most likely caused 
by CNVs or genetic mutations not yet associat‑
ed with the phenotype. Nevertheless, the patient 
remains symptomatic and the etiology of persis‑
tent CAD progression remains unknown.
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marginal branch, and RA to the second margin‑
al branch. Optimal medical therapy, which in‑
cluded dual antiplatelet therapy, β ‑blocker, and 
statin, was introduced and cessation of smoking 
was advised. The first episode of recurrent angi‑
na occurred in October 2011, and critical stenosis 
of the circumflex artery and the RIMA ‑LAD graft 
was treated by a drug ‑eluting stent (DES). Dur‑
ing follow ‑up, dyspnea, fatigue, and stable angi‑
na were observed. Computed tomographic angi‑
ography was performed to confirm the progres‑
sion of CAD. It  revealed an occluded RA ‑MgII 
graft due to disseminated vasculopathic lesions 
(FIGURE 1C and 1D) and a restenosis in the DES im‑
planted into the RIMA ‑LAD graft (FIGURE 1E and 1F). 
Despite smoking cessation and an intensified 
treatment with aspirin (75 mg/d orally), clopi‑
dogrel (75 mg/d orally), metoprolol (50 mg oral‑
ly every morning, 25 mg orally every evening), 
and rosuvastatin (20 mg/d orally), the results of 
lipid ‑lowering therapy remained unsatisfactory 
(total cholesterol, 3.7 mmol/l; low ‑density lipo‑
protein cholesterol, 2.01 mmol/l; high ‑density li‑
poprotein cholesterol, 1.11 mmol/l; and triglycer‑
ides, 2.34 mmol/l).
The patient was tested for hereditary and ac‑
quired hypercoagulable disorders, with nega‑
tive results. Moreover, lipoprotein metabolism 
FIGURE 1  
C, D – computed 
tomography showing 
the occluded radial artery 
to the second marginal 
branch graft (arrows);  
E – computed 
tomography showing 
restenosis in a drug‑
‑eluting stent (DES) 
implanted into the right 
internal mammary artery 
to the LAD graft (arrow);  
F – computed 
tomography showing 
a DES implanted into 
the circumflex artery 
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